
Assessment of BRAF V600E (VE1) immunochemistry for the detection of BRAF V600E mutation in non–small cell lung carcinoma cytology specimens
<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE1wdlF2UWNxeklVVUJkZW83aEp1STZNZFVCS0VPN3R2eC1MX2hqWS1UemNhX3ZyajlKUGRBVHctUlpvUmNMVEg1bWVWZXc0YXg3d2lJTVIwM0h6dllvOEtIcEtNMzdkRlJoVURQdER5eWpGNUJFXzIyLVhTaw?oc=5" target="_blank">Assessment of BRAF V600E (VE1) immunochemistry for the detection of BRAF V600E mutation in non–small cell lung carcinoma cytology specimens</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley & Sons</font>
